D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)

NCT00827281 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study was not funded and pilot work proved impractical.

Conditions

Smokers

Interventions

DRUG: D-cycloserine
DRUG: Placebo

Sponsor

Boston University Charles River Campus